Treating Risperdal-induced gynecomastia
Gynecomastia, or the abnormal growth of breast tissue among adolescent males, has been linked to the use of atypical anti-psychotic drug Risperdal. Over many years, more and more have been filing legal claims against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, saying that the companies failed to warn physicians and consumers about the risk of gynecomastia.
Because Risperdal-induced gynecomastia could be a result of the drug’s adverse effect on the pituitary gland, doctors may suggest treating the abnormality in the pituitary gland through medications or surgery. Furthermore, doctors may also suggest one of these surgical options in removing excess breast tissue:
- Mastectomy – The removal of the breast tissue and the breast gland itself
- Liposuction – This involves the removal of the breast tissues, but not the breast gland
Having a Risperdal-induced gynecomastia is financially costly and medically risky, and could have been prevented if the drug manufacturers have not failed to warn physicians about its dangers. If your loved one has suffered due to Risperdal, our legal team at Williams Kherkher might be of help. Call us at (800) 220-9341 for advice on how to take legal action.